Fu LW - Search Results

1

BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells.

He D, Zhao XQ, Chen XG, Fang Y, Singh S, Talele TT, Qiu HJ, Liang YJ, Wang XK, Zhang GQ, Chen ZS, Fu LW. He D, et al. Among authors: fu lw. PLoS One. 2013;8(1):e54181. doi: 10.1371/journal.pone.0054181. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349819 Free PMC article.

2

[Correlation between inhibitory effect of Manumycin on human hepatoma cancer cell HepG2 and Ras signal transduction pathway].

Zhou JM, Pan QC, Yang XP, Liu ZC, Liao DF, Fu LW, Liang YJ. Zhou JM, et al. Among authors: fu lw. Ai Zheng. 2002 Apr;21(4):364-8. Ai Zheng. 2002. PMID: 12452012 Chinese.

3

[Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].

Liang YJ, Fu LW, Ding Y, Xiong HY, Chen LM, Yang XP, Pan QC. Liang YJ, et al. Among authors: fu lw. Ai Zheng. 2003 Apr;22(4):368-71. Ai Zheng. 2003. PMID: 12703990 Chinese.

4

Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2.

Fu LW, He LR, Liang YJ, Chen LM, Xiong HY, Yang XP, Pan QC. Fu LW, et al. Yao Xue Xue Bao. 2003 Aug;38(8):565-70. Yao Xue Xue Bao. 2003. PMID: 14628443

5

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.

Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q. Fu L, et al. Cancer Chemother Pharmacol. 2004 Apr;53(4):349-56. doi: 10.1007/s00280-003-0742-5. Epub 2003 Dec 10. Cancer Chemother Pharmacol. 2004. PMID: 14666379

6

[Arsenic trioxide induced cell apoptosis by mitochondria dependent pathway in KB and KBv200 cells].

Li YF, Wang XD, Liang YJ, Chen LM, Ding Y, Huang M, Fu LW. Li YF, et al. Among authors: fu lw. Ai Zheng. 2004 Jun;23(6):631-4. Ai Zheng. 2004. PMID: 15191660 Chinese.

7

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.

Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW. Chen LM, et al. Among authors: fu lw. J Pharm Pharmacol. 2004 Aug;56(8):1061-6. doi: 10.1211/0022357043879. J Pharm Pharmacol. 2004. PMID: 15285852

8

Screening novel, potent multidrug-resistant modulators from imidazole derivatives.

Chen LM, Wu XP, Ruan JW, Liang YJ, Ding Y, Shi Z, Wang XW, Gu LQ, Fu LW. Chen LM, et al. Among authors: fu lw. Oncol Res. 2004;14(7-8):355-62. doi: 10.3727/0965040041292378. Oncol Res. 2004. PMID: 15301426

9

[Enhancement of FG020326 on sensitivity of MCF-7/ADR cells to taxotere via enhancing activation of caspase-8 and caspase-3].

Wang XW, Ding Y, Liang YJ, Chen LM, Shi Z, Yang XP, Gu LQ, Fu LW. Wang XW, et al. Among authors: fu lw. Ai Zheng. 2004 Nov;23(11 Suppl):1379-85. Ai Zheng. 2004. PMID: 15566641 Chinese.

10

[Reversal of multidrug resistance of tumor cells by FG020327 and its mechanism].

Chen LM, Li YF, Zhang X, Yan SL, Liang YJ, Fu LW. Chen LM, et al. Among authors: fu lw. Ai Zheng. 2005 Feb;24(2):189-93. Ai Zheng. 2005. PMID: 15694031 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters